1 PYC THERAPEUTICS LIMITED (ACN 098 391 961) Corporate Governance Statement – 30 th June 2026 1.1 ASX Corporate Governance Council Principles and Recommendations PYC Therapeutics Limited (“Company”)(“PYC”) has adopted systems of control and accountability as the basis for...
2026 Corporate Governance Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Earlier from PYC Therapeutics
- Appendix 4G
- 2026 Annual Report to Shareholders
- Appendix 4E
- Notification regarding unquoted securities - PYC
- Investor Webinar
Later from PYC Therapeutics
- PKD - Presentation of Clinical Safety Data
- Ceasing to be a substantial holder
- ADOA Program - Data Presentation
- Investor Webinar Presentation Q3 2026
- S&P DJI Announces September 2026 Quarterly Rebalance
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics